Evidence map›Paper›PMID 24648181›Full record

ArticleHippocampus2014

Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice.

Balapal S Basavarajappa, Nagaraja N Nagre, Shan Xie, Shivakumar Subbanna

Open access · greenAbstract read
In one paragraph

Article in Hippocampus, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAClinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2023
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Alleviating CB2-Dependent ER Stress and Mitochondrial Dysfunction Improves Chronic Cerebral Hypoperfusion-Induced Cognitive Impairment.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  9. Article
  10. Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Balapal S BasavarajappaDivision of Analytical Psychopharmacology, Nathan Kline Institute for Psychiatric Research, Orangeburg, New York; New York State Psychiatric Institute, College of Physicians & Surgeons, Columbia University, New York, New York; Department of Psychiatry, College of Physicians & Surgeons, Columbia University, New York, New York.
Nagaraja N Nagre
Shan Xie
Shivakumar Subbanna
Nathan Kline Institute for Psychiatric Research · US

Funding

Endocannabinoid Signaling in Postnatal Ethanol EffectsR01AA019443 · NIAAA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI BALAPAL, BASAVARAJ S · 2010 to 2019
$3.2M
NIAAA NIH HHS AA019443NIAAA NIH HHS R01 AA019443
6 · The paper itself

Abstract

In rodents, many exogenous and endogenous cannabinoids, such as anandamide (AEA) and 2-arachidonyl glycerol (2-AG), have been shown to play an important role in certain hippocampal memory processes. However, the mechanisms by which endogenous AEA regulate this processes are not well understood. Here the effects of AEA on long-term potentiation (LTP), hippocampal-dependent learning and memory tasks, pERK1/2, pCaMKIV, and pCREB signaling events in both cannabinoid receptor type 1 (CB1R) wild-type (WT) and knockout (KO) mice were assessed following administration of URB597, an inhibitor of the fatty acid amide hydrolase (FAAH). Acute administration of URB597 enhanced AEA levels without affecting the levels of 2-AG or CB1R in the hippocampus and neocortex as compared to vehicle. In hippocampal slices, URB597 impaired LTP in CB1R WT but not in KO littermates. URB597 impaired object recognition, spontaneous alternation and spatial memory in the Y-maze test in CB1R WT mice but not in KO mice. Furthermore, URB597 enhanced ERK phosphorylation in WT without affecting total ERK levels in WT or KO mice. URB597 impaired CaMKIV and CREB phosphorylation in WT but not in KO mice. CB1R KO mice have a lower pCaMKIV/CaMKIV ratio and higher pCREB/CREB ratio as compared to WT littermates. Our results indicate that pharmacologically elevated AEA impair LTP, learning and memory and inhibit CaMKIV and CREB phosphorylation, via the activation of CB1Rs. Collectively, these findings also suggest that pharmacological elevation of AEA beyond normal concentrations is also detrimental for the underlying physiological responses.

Indexed as

AmidohydrolasesAnimalsArachidonic AcidsBenzamidesCalcium-Calmodulin-Dependent Protein Kinase Type 4CarbamatesCyclic AMP Response Element-Binding ProteinEndocannabinoidsFatty Acid Amide HydrolasesGlyceridesLearningLong-Term PotentiationMaleMAP Kinase Signaling SystemMaze LearningMemoryAmidohydrolasesanandamideArachidonic AcidsBenzamidesCalcium-Calmodulin-Dependent Protein Kinase Type 4CarbamatesCnr1 protein, ratCreb1 protein, mouseCyclic AMP Response Element-Binding Proteincyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl esterEndocannabinoidsFatty Acid Amide HydrolasesGlyceridesglyceryl 2-arachidonatePolyunsaturated AlkamidesReceptor, Cannabinoid, CB1anandamideCaMKIV phosphorylationCB1 null miceCREBfatty acid amide hydrolaselong-term potentiationmitogen-activated protein kinaseURB597

Identifiers

PMID24648181
PMCPMC4077345
OpenAlexW1599900536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.